PAYCOR HCM INC (PYCR) Fundamental Analysis & Valuation

NASDAQ:PYCR • US70435P1021

Current stock price

22.49 USD
+0.04 (+0.18%)
At close:
22.49 USD
0 (0%)
After Hours:

This PYCR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. PYCR Profitability Analysis

1.1 Basic Checks

  • In the past year PYCR was profitable.
  • In the past year PYCR had a positive cash flow from operations.
  • PYCR had negative earnings in each of the past 5 years.
  • PYCR had a positive operating cash flow in each of the past 5 years.
PYCR Yearly Net Income VS EBIT VS OCF VS FCFPYCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • With a Return On Assets value of -0.76%, PYCR is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
  • PYCR's Return On Equity of -1.64% is on the low side compared to the rest of the industry. PYCR is outperformed by 68.67% of its industry peers.
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROIC N/A
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
PYCR Yearly ROA, ROE, ROICPYCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -2 -4 -6 -8 -10

1.3 Margins

  • PYCR has a better Gross Margin (65.97%) than 77.11% of its industry peers.
  • PYCR's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PYCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
PYCR Yearly Profit, Operating, Gross MarginsPYCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PYCR Health Analysis

2.1 Basic Checks

  • PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PYCR has more shares outstanding
  • PYCR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PYCR has a worse debt to assets ratio.
PYCR Yearly Shares OutstandingPYCR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PYCR Yearly Total Debt VS Total AssetsPYCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.64, we must say that PYCR is in the distress zone and has some risk of bankruptcy.
  • PYCR's Altman-Z score of 1.64 is on the low side compared to the rest of the industry. PYCR is outperformed by 63.86% of its industry peers.
  • PYCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.64
ROIC/WACCN/A
WACC8.98%
PYCR Yearly LT Debt VS Equity VS FCFPYCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
  • PYCR has a Current ratio (1.12) which is in line with its industry peers.
  • A Quick Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.12, PYCR is in line with its industry, outperforming 43.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
PYCR Yearly Current Assets VS Current LiabilitesPYCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PYCR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 27.73% over the past year.
  • PYCR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.73%.
  • PYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.57% yearly.
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%

3.2 Future

  • PYCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.73% yearly.
  • The Revenue is expected to grow by 12.08% on average over the next years. This is quite good.
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PYCR Yearly Revenue VS EstimatesPYCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PYCR Yearly EPS VS EstimatesPYCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. PYCR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.16, PYCR can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, PYCR is valued a bit more expensive than 72.29% of the companies in the same industry.
  • PYCR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.96.
  • PYCR is valuated quite expensively with a Price/Forward Earnings ratio of 34.02.
  • Based on the Price/Forward Earnings ratio, PYCR is valued a bit more expensive than the industry average as 60.24% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of PYCR to the average of the S&P500 Index (24.04), we can say PYCR is valued slightly more expensively.
Industry RankSector Rank
PE 40.16
Fwd PE 34.02
PYCR Price Earnings VS Forward Price EarningsPYCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 71.08% of the companies listed in the same industry.
  • PYCR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 65.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 71.33
EV/EBITDA 34.15
PYCR Per share dataPYCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as PYCR's earnings are expected to grow with 16.50% in the coming years.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y14.99%
EPS Next 3Y16.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PYCR Dividend Analysis

5.1 Amount

  • No dividends for PYCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PYCR Fundamentals: All Metrics, Ratios and Statistics

PAYCOR HCM INC

NASDAQ:PYCR (4/11/2025, 8:18:17 PM)

After market: 22.49 0 (0%)

22.49

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05
Earnings (Next)05-07
Inst Owners42.91%
Inst Owner Change-99.9%
Ins Owners1.17%
Ins Owner Change0%
Market Cap4.09B
Revenue(TTM)699.73M
Net Income(TTM)-21.43M
Analysts55.24
Price Target22.74 (1.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.63%
Min EPS beat(2)20.66%
Max EPS beat(2)28.59%
EPS beat(4)4
Avg EPS beat(4)17.12%
Min EPS beat(4)3.43%
Max EPS beat(4)28.59%
EPS beat(8)8
Avg EPS beat(8)25.77%
EPS beat(12)12
Avg EPS beat(12)33.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.24%
Revenue beat(8)6
Avg Revenue beat(8)0.4%
Revenue beat(12)10
Avg Revenue beat(12)1.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.07%
EPS NY rev (1m)-1.19%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 40.16
Fwd PE 34.02
P/S 5.84
P/FCF 71.33
P/OCF 34.44
P/B 3.12
P/tB 12.25
EV/EBITDA 34.15
EPS(TTM)0.56
EY2.49%
EPS(NY)0.66
Fwd EY2.94%
FCF(TTM)0.32
FCFY1.4%
OCF(TTM)0.65
OCFY2.9%
SpS3.85
BVpS7.2
TBVpS1.84
PEG (NY)2.2
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.97%
FCFM 8.19%
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 47.16%
Cap/Sales 8.77%
Interest Coverage N/A
Cash Conversion 102.02%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.64
F-Score6
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)42.74%
Cap/Depr(5y)34.82%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%
EBIT growth 1Y83.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.22%
EBIT Next 3Y44.32%
EBIT Next 5Y41.74%
FCF growth 1Y324.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.14%
OCF growth 3Y102.92%
OCF growth 5YN/A

PAYCOR HCM INC / PYCR Fundamental Analysis FAQ

What is the fundamental rating for PYCR stock?

ChartMill assigns a fundamental rating of 3 / 10 to PYCR.


What is the valuation status of PAYCOR HCM INC (PYCR) stock?

ChartMill assigns a valuation rating of 0 / 10 to PAYCOR HCM INC (PYCR). This can be considered as Overvalued.


What is the profitability of PYCR stock?

PAYCOR HCM INC (PYCR) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for PYCR stock?

The Price/Earnings (PE) ratio for PAYCOR HCM INC (PYCR) is 40.16 and the Price/Book (PB) ratio is 3.12.


What is the earnings growth outlook for PAYCOR HCM INC?

The Earnings per Share (EPS) of PAYCOR HCM INC (PYCR) is expected to grow by 18.26% in the next year.